Stanford scientists discovered that a harmless skin bacterium triggers a powerful immune response. By tweaking a bacterial ...

Nigeria study results show how using Tropis for routine immunization programs can provide significant benefits at all levels ...

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

Vaxxas’ proprietary high-density microarray patch (HD-MAP) technology is currently being evaluated in a phase 1 clinical study of the first needle-free COVID-19 vaccine, having demonstrated ...

The patch-delivered vaccine trial received $28.5m in funding from US authorities as a potential pandemic preparation.

In this section you'll find photographic features that explore holidays and photography courses, details about members meetings, trials and tribulations of installing new software along with ...

Through his public-benefit corporation Star Syringe, Koska first needed to embark on a public policy and advocacy campaign to ...

A Saharanpur court has ordered UP police to file a case against a woman's in-laws for allegedly injecting her with an ...

Vaxxas, a clinical-stage biotechnology company, today announced it has completed enrollment for its Phase I clinical trial of a vaccine against an avian influenza A (H7N9) virus with pandemic ...

Sarah avoided needles so long she had to be rushed to hospital and medics said she was at risk of a heart attack and lifelong paralysis ...

This study demonstrated that 32-G 5-mm needles can be reliably inserted into subcutaneous fat, are relatively pain free, and are associated with minimal leakage from the injection site.